mir1260b: MIR1260B is a microRNA implicated in various cellular processes and has been identified as a potential biomarker in cancer research [PMC8504092]. Analysis has revealed that miR-1260b is closely associated with the Serine/Threonine-protein kinase family, including CHEK2 and CDK4, which are important in cell cycle regulation [PMC8504092]. It has been suggested that miR-1260b, along with miR1260a, shows differential expression in the peripheral blood of ovarian cancer patients compared to healthy controls, indicating potential prognostic and diagnostic significance [PMC8504092]. Furthermore, common gene targets of MIR1260B have been identified to interact at the protein level [PMC8504092]. In prostate cancer (PCa), MIR1260B expression can be modulated by genistein, which affects cell proliferation by altering both oncogenic and oncosuppressor microRNAs [PMC7072821]. Additionally, MIR1260B interacts with various protein-coding genes and non-coding RNAs including HNRNPK, suggesting a complex regulatory network influenced by this microRNA [PMC9730017]. Inhibition of MIR1260B has been shown to affect cell proliferation in colorectal cancer cells when combined with chemotherapeutic agents like 5-FU [PMC6144919], while genistein-mediated down-regulation of MIR1260B can decrease PCa cell proliferation through epigenetic modifications [PMC5068501].